{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T12:17:34Z","timestamp":1770553054940,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,7]]},"DOI":"10.7759\/cureus.103154","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:16:40Z","timestamp":1770470200000},"source":"Crossref","is-referenced-by-count":0,"title":["Mind and Muscle: A Retrospective Study on the Management of Psychiatric Comorbidities in Patients With Fibromyalgia Treated With Pregabalin Versus Milnacipran"],"prefix":"10.7759","author":[{"given":"Angelica","family":"Arshoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S","family":"Murdock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo D","family":"Espiridion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe F","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, et al.. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33:160-72. 10.1002\/art.1780330203","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa061","article-title":"Diagnosis of fibromyalgia: comparison of the 2011\/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status","volume":"59","author":"Salaffi F","year":"2020","unstructured":"Salaffi F, Di Carlo M, Farah S, et al.. Diagnosis of fibromyalgia: comparison of the 2011\/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. Rheumatology (Oxford). 2020, 59:3042-9. 10.1093\/rheumatology\/keaa061","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini P","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020, 16:645-60. 10.1038\/s41584-020-00506-w","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project","volume":"65","author":"Vincent A","year":"2013","unstructured":"Vincent A, Lahr BD, Wolfe F, et al.. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013, 65:786-92. 10.1002\/acr.21896","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04750-8","article-title":"Physical activity, sedentary behaviour, physical fitness, and cognitive performance in women with fibromyalgia who engage in reproductive and productive work: the al-\u00c1ndalus project","volume":"38","author":"\u00c1lvarez-Gallardo IC","year":"2019","unstructured":"\u00c1lvarez-Gallardo IC, Est\u00e9vez-L\u00f3pez F, Torres-Aguilar XC, et al.. Physical activity, sedentary behaviour, physical fitness, and cognitive performance in women with fibromyalgia who engage in reproductive and productive work: the al-\u00c1ndalus project. Clin Rheumatol. 2019, 38:3585-93. 10.1007\/s10067-019-04750-8","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbre.2017.01.005","article-title":"Prevalence of fibromyalgia: literature review update","volume":"57","author":"Marques AP","year":"2017","unstructured":"Marques AP, Santo AS, Berssaneti AA, Matsutani LA, Yuan SL. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017, 57:356-63. 10.1016\/j.rbre.2017.01.005","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2017.6622","article-title":"Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: a national veterans Health Administration study","volume":"27","author":"Arout CA","year":"2018","unstructured":"Arout CA, Sofuoglu M, Bastian LA, Rosenheck RA. Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: a national veterans Health Administration study. J Womens Health (Larchmt). 2018, 27:1035-44. 10.1089\/jwh.2017.6622","journal-title":"J Womens Health (Larchmt)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2009.07.002","article-title":"Axis I and axis II psychiatric disorders in patients with fibromyalgia","volume":"32","author":"Uguz F","year":"2010","unstructured":"Uguz F, Ci\u00e7ek E, Salli A, Karahan AY, Albayrak I, Kaya N, U\u011furlu H. Axis I and axis II psychiatric disorders in patients with fibromyalgia. Gen Hosp Psychiatry. 2010, 32:105-7. 10.1016\/j.genhosppsych.2009.07.002","journal-title":"Gen Hosp Psychiatry"},{"key":"ref9","article-title":"Fibromyalgia and psychiatric disorders","volume":"78","author":"Fietta P","year":"2007","unstructured":"Fietta P, Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed. 2007, 78:88-95.","journal-title":"Acta Biomed"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000146329.63158.40","article-title":"Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables","volume":"66","author":"Thieme K","year":"2004","unstructured":"Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004, 66:837-44. 10.1097\/01.psy.0000146329.63158.40","journal-title":"Psychosom Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v67n0807","article-title":"Comorbidity of fibromyalgia and psychiatric disorders","volume":"67","author":"Arnold LM","year":"2006","unstructured":"Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006, 67:1219-25. 10.4088\/jcp.v67n0807","journal-title":"J Clin Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.05.031","article-title":"Opioid use, misuse, and abuse in patients labeled as fibromyalgia","volume":"124","author":"Fitzcharles MA","year":"2011","unstructured":"Fitzcharles MA, Ste-Marie PA, Gamsa A, Ware MA, Shir Y. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med. 2011, 124:955-60. 10.1016\/j.amjmed.2011.05.031","journal-title":"Am J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06407-5","article-title":"Centralized nociplastic pain causing fibromyalgia: an emperor with no cloths?","volume":"41","author":"Mart\u00ednez-Lav\u00edn M","year":"2022","unstructured":"Mart\u00ednez-Lav\u00edn M. Centralized nociplastic pain causing fibromyalgia: an emperor with no cloths?. Clin Rheumatol. 2022, 41:3915-7. 10.1007\/s10067-022-06407-5","journal-title":"Clin Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06229-5","article-title":"Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia","volume":"41","author":"Bidari A","year":"2022","unstructured":"Bidari A, Ghavidel-Parsa B. Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia. Clin Rheumatol. 2022, 41:2939-47. 10.1007\/s10067-022-06229-5","journal-title":"Clin Rheumatol"},{"key":"ref15","unstructured":"Centers for Disease Control and Prevention. Fibromyalgia. (2022). Accessed: 10\/10\/2024: https:\/\/www.cdc.gov\/chronic-disease\/fibromyalgia\/index.html."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123070","article-title":"Fibromyalgia pathophysiology","volume":"10","author":"Gyorfi M","year":"2022","unstructured":"Gyorfi M, Rupp A, Abd-Elsayed A. Fibromyalgia pathophysiology. Biomedicines. 2022, 10:10.3390\/biomedicines10123070","journal-title":"Biomedicines"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4637.2001.01030.x","article-title":"Evidence for abnormal pain processing in fibromyalgia syndrome","volume":"2","author":"Staud R","year":"2001","unstructured":"Staud R, Domingo M. Evidence for abnormal pain processing in fibromyalgia syndrome. Pain Med. 2001, 2:208-15. 10.1046\/j.1526-4637.2001.01030.x","journal-title":"Pain Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106492","article-title":"Glutamatergic systems in neuropathic pain and emerging non-opioid therapies","volume":"185","author":"Temmermand R","year":"2022","unstructured":"Temmermand R, Barrett JE, Fontana AC. Glutamatergic systems in neuropathic pain and emerging non-opioid therapies. Pharmacol Res. 2022, 185:106492. 10.1016\/j.phrs.2022.106492","journal-title":"Pharmacol Res"},{"key":"ref19","article-title":"Biochemistry, substance P","author":"Graefe SB","year":"2023","unstructured":"Graefe SB, Rahimi N, Mohiuddin SS. Biochemistry, substance P. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-006-0020-4","article-title":"Is serotonin hyperalgesic or analgesic?","volume":"10","author":"Sommer C","year":"2006","unstructured":"Sommer C. Is serotonin hyperalgesic or analgesic?. Curr Pain Headache Rep. 2006, 10:101-6. 10.1007\/s11916-006-0020-4","journal-title":"Curr Pain Headache Rep"},{"key":"ref21","unstructured":"Food and Drug Administration. FDA approves first generics of Lyrica. (2025). https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-generics-lyrica."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials","volume":"145","author":"H\u00e4user W","year":"2009","unstructured":"H\u00e4user W, Bernardy K, U\u00e7eyler N, Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain. 2009, 145:69-81. 10.1016\/j.pain.2009.05.014","journal-title":"Pain"},{"key":"ref23","article-title":"Milnacipran (Savella), a treatment option for fibromyalgia","volume":"35","author":"English C","year":"2010","unstructured":"English C, Rey JA, Rufin C. Milnacipran (Savella), a treatment option for fibromyalgia. P T. 2010, 35:261-6.","journal-title":"P T"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1047343","article-title":"An update on pharmacotherapy for the treatment of fibromyalgia","volume":"16","author":"Calandre EP","year":"2015","unstructured":"Calandre EP, Rico-Villademoros F, Slim M. An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opin Pharmacother. 2015, 16:1347-68. 10.1517\/14656566.2015.1047343","journal-title":"Expert Opin Pharmacother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user W","year":"2013","unstructured":"H\u00e4user W, Urr\u00fatia G, Tort S, U\u00e7eyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev. 2013, CD010292. 10.1002\/14651858.CD010292","journal-title":"Cochrane Database Syst Rev"},{"key":"ref26","unstructured":"U.S. Department of Health and Human Services. Definition of human subjects research. (2024). Accessed: 10\/10\/2024: https:\/\/grants.nih.gov\/policy-and-compliance\/policy-topics\/human-subjects\/research."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111087","article-title":"Mortality risk and causes of death among people who use opioids in a take-home naloxone cohort","volume":"255","author":"Ericson \u00d8B","year":"2024","unstructured":"Ericson \u00d8B, Eide D, Lobmaier P, Clausen T. Mortality risk and causes of death among people who use opioids in a take-home naloxone cohort. Drug Alcohol Depend. 2024, 255:111087. 10.1016\/j.drugalcdep.2024.111087","journal-title":"Drug Alcohol Depend"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/164_2018_164","article-title":"Serotonin and norepinephrine reuptake inhibitors","volume":"250","author":"Shelton RC","year":"2019","unstructured":"Shelton RC. Serotonin and norepinephrine reuptake inhibitors. Handb Exp Pharmacol. 2019, 250:145-80. 10.1007\/164_2018_164","journal-title":"Handb Exp Pharmacol"},{"key":"ref29","article-title":"Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison","volume":"11","author":"Sansone RA","year":"2014","unstructured":"Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014, 11:37-42.","journal-title":"Innov Clin Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/445886-mind-and-muscle-a-retrospective-study-on-the-management-of-psychiatric-comorbidities-in-patients-with-fibromyalgia-treated-with-pregabalin-versus-milnacipran","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:16:48Z","timestamp":1770470208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/445886-mind-and-muscle-a-retrospective-study-on-the-management-of-psychiatric-comorbidities-in-patients-with-fibromyalgia-treated-with-pregabalin-versus-milnacipran"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.103154","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,7]]}}}